Dataset from A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00010623
下载链接
链接失效反馈官方服务：
资源简介：
A clinical study to evaluate the efficacy and safety of solifenacin in patients with bladder symptoms due to spinal cord injury or multiple sclerosis
一项针对脊髓损伤（spinal cord injury）或多发性硬化（multiple sclerosis）所致膀胱症状患者，评估索利那新（solifenacin）疗效与安全性的临床研究
创建时间：
2025-02-10
